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Abstract
Ethanol is widely used in all kinds of products with direct exposure to the human skin (e.g. medicinal
products like hand disinfectants in occupational settings, cosmetics like hairsprays or mouthwashes,
pharmaceutical preparations, and many household products). Contradictory evidence about the
safety of such topical applications of the alcohol can be found in the scientific literature, yet an up-
to-date risk assessment of ethanol application on the skin and inside the oral cavity is currently
lacking.
The first and foremost concerns of topical ethanol applications for public health are its carcinogenic
effects, as there is unambiguous evidence for the carcinogenicity of ethanol orally consumed in the
form of alcoholic beverages. So far there is a lack of evidence to associate topical ethanol use with
an increased risk of skin cancer. Limited and conflicting epidemiological evidence is available on the
link between the use of ethanol in the oral cavity in the form of mouthwashes or mouthrinses and
oral cancer. Some studies pointed to an increased risk of oral cancer due to locally produced
acetaldehyde, operating via a similar mechanism to that found after alcoholic beverage ingestion.
In addition, topically applied ethanol acts as a skin penetration enhancer and may facilitate the
transdermal absorption of xenobiotics (e.g. carcinogenic contaminants in cosmetic formulations).
Ethanol use is associated with skin irritation or contact dermatitis, especially in humans with an
aldehyde dehydrogenase (ALDH) deficiency.
After regular application of ethanol on the skin (e.g. in the form of hand disinfectants) relatively low
but measurable blood concentrations of ethanol and its metabolite acetaldehyde may occur, which
are, however, below acute toxic levels. Only in children, especially through lacerated skin, can
percutaneous toxicity occur.
As there might be industry bias in many studies about the safety of topical ethanol applications, as
well as a general lack of scientific research on the long-term effects, there is a requirement for
independent studies on this topic. The research focus should be set on the chronic toxic effects of
ethanol and acetaldehyde at the point of impact, with special regard to children and individuals with
genetic deficiencies in ethanol metabolism.
Published: 13 November 2008
Journal of Occupational Medicine and Toxicology 2008, 3:26 doi:10.1186/1745-6673-3-26
Received: 5 September 2008
Accepted: 13 November 2008
This article is available from: http://www.occup-med.com/content/3/1/26
© 2008 Lachenmeier; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Occupational Medicine and Toxicology 2008, 3:26 http://www.occup-med.com/content/3/1/26
Page 2 of 16
(page number not for citation purposes)
Introduction
Ethanol is widely used as a solvent both in the home and
in industry [1]. Consumers may be exposed to ethanol
from its application as a constituent of many household
and personal products, such as cosmetics, hairsprays, win-
dow cleaners, de-icers and certain pharmaceutical prepa-
rations [2]. Most people have experienced skin contact
with alcoholic solutions [1].
The safety of topical applications of ethanol is still a mat-
ter of debate, and there appears to be scientific evidence
pointing in both directions. On the one hand, researchers
came to the conclusion that the range of damage caused
to the skin by the alcohol cannot and should not be
ignored, although the deleterious effects of ethanol expo-
sure on the skin may pale into insignificance compared to
its effects on the liver, central nervous system, and other
body systems after ingestion [3]. On the other hand, sci-
entific studies attributed ethanol for topical uses as safe
per se [1,4-7]. However, there appears to be at least some
evidence, including epidemiological data, about mouth-
wash use, and data from animal experiments showing that
ethanol on the skin or inside the oral cavity may cause
harm if used chronically. Evaluation according to EU cos-
metics legislation [8] and other acts about chemical safety
should consider the chronic toxic and carcinogenic poten-
tial of ethanol. In this article, the safety of topical uses of
ethanol will be evaluated by a critical review of the scien-
tific literature.
Methods
Data on the safety of topical ethanol were obtained by a
computer-assisted literature search using the key words
"topical ethanol", "topical alcohol", mouthwash,
mouthrinse, "hand disinfectant", "alcohol based disin-
fectant" "alcohol/ethanol & melanoma", "alcohol/etha-
nol & skin" "alcohol/ethanol & penetration", "alkanol
permeation", "acetaldehyde & skin". Searches in both
English and German were carried out in July 2008, in the
following databases: PubMed, Toxnet and ChemIDplus
(U.S. National Library of Medicine, Bethesda, MD), Web
of Science (Thomson Scientific, Philadelphia, PA), IPCS/
INCHEM (International Programme on Chemical Safety/
Chemical Safety Information from Intergovernmental
Organizations, WHO, Geneva, Switzerland), and Scopus
(Elsevier B.V., Amsterdam, Netherlands). This was accom-
panied by a hand search of the reference lists of all articles
for any relevant studies not included in the databases. The
references, including abstracts, were imported into Refer-
ence Manager V.11 (Thomson ISI Research Soft, Carlsbad,
CA) and the relevant articles were manually identified and
purchased in full text.
Review
Most research on ethanol is centred around its effects after
ingestion in the form of alcoholic beverages, which is a
major risk factor for the burden of disease in our society
[9]. Significantly less information is available on the
effects of ethanol if topically used on human skin or in the
oral cavity. Our discussion will begin with the mecha-
nisms of toxicity known from ethanol ingestion, for
which there is evidence that they could also apply to top-
ical ethanol use (i.e. carcinogenicity and local effects of
ethanol on the human skin). After that, the effects of eth-
anol as a skin penetration enhancer will be discussed,
which are excellently described from pharmaceutical
applications. Finally, certain groups of products are dis-
cussed in detail (cosmetics, mouthwashes, and hand dis-
infectants), and an overall risk assessment is provided.
Carcinogenicity of ethanol: is there a possibility of skin 
cancer after topical application?
The recent evaluation of ethanol in alcoholic beverages as
'carcinogenic to humans' must be considered in the risk
assessment of topical application forms. This paragraph
summarizes the scientific proof for this association, which
has been primarily derived from epidemiological studies
about the ingestion of alcoholic beverages.
In February 2007, the WHO's International Agency for
Research on Cancer (IARC) re-assessed the carcinogenicity
of alcoholic beverages in the context of the IARC mono-
graphs programme. 'Ethanol in alcoholic beverages' was
classified as 'carcinogenic to humans' (Group 1) [10,11].
Overall, the IARC concluded that the occurrence of malig-
nant tumors of the oral cavity, pharynx, larynx, esopha-
gus, liver, colorectum, and female breast is causally related
to alcohol consumption [11]. Because the associations
were generally noted with different types of alcoholic bev-
erages, and in view of the carcinogenicity of ethanol in
animals, the IARC now considers ethanol itself (not other
constituents or contaminants) as causative of the carcino-
genicity of alcoholic beverages.
Many studies of different design and in different popula-
tions around the world have consistently shown that reg-
ular alcohol consumption is associated with an increased
risk of cancers of the oral cavity, pharynx, larynx, and
esophagus [12]. Daily consumption of around 50 g of
alcohol (ethanol) increases the risk of these cancers by
two to three times compared to non-drinkers [11,13-15].
Furthermore, in populations that are deficient in the activ-
ity of aldehyde dehydrogenase, an enzyme involved in the
catabolism of ethanol, much higher risks for oesophageal
cancer after alcohol consumption have been reported
than in populations with a fully active enzyme [16]. This
is also proof that acetaldehyde derived from ethanolJournal of Occupational Medicine and Toxicology 2008, 3:26 http://www.occup-med.com/content/3/1/26
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metabolism contributes to its carcinogenicity. Results of
animal experiments have confirmed the carcinogenicity of
acetaldehyde and ethanol [11].
During topical-application of ethanol, the most prone
organ for adverse effects appears to be the skin, which
comes into direct contact with the agent. The second
organ that may be regularly exposed to topical ethanol is
the oral cavity through use of alcohol-containing mouth-
washes or mouthrinses.
In their evaluation of the carcinogenicity of alcoholic bev-
erages and ethanol, the IARC also appreciated the associ-
ation between melanoma and alcohol consumption [10].
The IARC considered two cohort studies, one in an occu-
pational group exposed to ionizing radiation and one in
alcoholic women. In the cohort study of radiologic tech-
nologists in the U.S.A. and in the study of alcoholic
women in Sweden, no significant associations were seen
[17,18]. Furthermore, a number of case-control studies
published results on melanoma risk in relation to alcohol
intake. Some of those studies reported no significant asso-
ciation between alcohol intake and melanoma risk [19-
23]. Whereas, three case-control studies in the U.S.A.
reported some increase in risk of melanoma associated
with alcohol intake [24-26]. None of these were adjusted
for exposure to UV light, and thus the possibility of con-
founding cannot be excluded. The IARC concluded that
melanoma is not one of the cancer sites with a clear asso-
ciation with ethanol consumption. Besides melanoma, a
few studies have linked alcohol consumption to a higher
risk of basal cell carcinoma [27,28].
Only a few studies have suggested potential biological
mechanisms for a possible relationship between alcohol
and melanoma risk [17]. The high-risk behaviour of binge
and heavy drinking may be associated with higher rates of
sunburn, which may lead to skin cancer [29]. A pituitary-
mediated mechanism has been proposed as a direct effect
of ethanol [30,31]. Another hypothesis on the aetiology
of alcohol induced melanoma is an altered redox state
caused by alcohol metabolism [32]. Ethanol ingestion
may also lead to a decrease of carotenoid antioxidant sub-
stances in the skin, which then causes erythema to occur
faster and with greater intensity following UV irradiation
[33].
Interesting evidence into the induction of melanoma and
non-melanoma skin cancers is provided by the animal
experiments of Strickland et al. [34-36]. The studies sug-
gest that the interaction of topically applied compounds
like ethanol and Aloe emodin (a trihydroxyanthraqui-
none found in Aloe barbadensis), may be, in conjunction
with UV radiation, important in causing melanin-contain-
ing tumours. As an underlying mechanism the authors
speculated that the anaerobic flora of the pilosebaceous
unit transforms ethanol to acetaldehyde and thus fosters
ethanol-based carcinogenesis. The authors found that
their research may pose public health implications due to
the presence of these compounds in consumer products,
especially the simultaneous use of ethanol and the gel of
Aloe barbadensis, which forms the basis of a large number
of skin care products, under exposure of UV light. How-
ever, it remained undetermined if the results from animal
experiments may be transferable to humans.
All in all, it can be concluded that there is a lack of evi-
dence to associate topical ethanol use with an increased
risk of skin cancer. However, the carcinogenic properties
of ethanol must be regarded in the risk assessment of such
products anyway, because ethanol may be transported by
the blood stream to more susceptible organs after skin
penetration (see below). The synergistic effects with Aloe
barbadensis show that each formulation of an ethanol con-
taining product must be thoroughly evaluated for its car-
cinogenic potential.
Other effects of ethanol on the skin
Besides skin cancer, alcohol abuse has been associated
with the development of several skin disorders including
psoriasis, discoid eczema and superficial infections [37-
40]. Chronic alcohol abuse is also a predisposing factor
for necrotizing wound infections, delayed wound healing
and cellulitis [41]. There are several theories about the
causes for such skin diseases including immune suppres-
sion, mal-nutrition, liver disease [42] or the influence of
alcohol on lipid metabolism [43]. As acute and chronic
alcohol abuse modulate immunity [44], this mechanism
can explain dermatological diseases, which have an
immune pathogenetic mechanism [42]. However, there
are only a few studies about the molecular mechanisms of
alcoholic skin diseases. Farkas et al. [45] determined a
stimulatory effect of ethanol on human keratinocytes,
which may be one of the reasons why psoriasis can be pre-
cipitated by alcohol misuse.
Topical application of 10% ethanol stimulates the prolif-
eration of peritoneal tissue explants – a semi in-vivo
wound model – which can be interpreted as positive influ-
ence for stimulation of wound healing by ethanol [46].
An interesting patch test was conducted by Haddock et al.
[47]. 1.5-cm patches moistened with 0.1 ml of 100% eth-
anol or 10% acetaldehyde were applied to a group of
patients. No erythema were observed from patch tests
with ethanol on non-hydrated skin, while all applications
of acetaldehyde resulted in notable erythema. Using the
same test on hydrated skin (i.e. immersion of the test site
in water for 10 min before application of the patches),
localized erythema were also caused by ethanol. The reac-Journal of Occupational Medicine and Toxicology 2008, 3:26 http://www.occup-med.com/content/3/1/26
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tions were judged to represent a direct pharmacologic
action of topical alcohols on the cutaneous microvascula-
ture, and that erythemogenesis is enhanced after hydra-
tion because of an increase in cutaneous permeability to
alcohol.
Höök-Nikanne et al. [48] found that very high acetalde-
hyde levels up to 960 μmol/l were formed in vitro by dif-
ferent bacteria strains typically found on the human skin
at ethanol concentrations known to exist in sweat during
normal social drinking. The authors concluded that this
primary observation of bacterial production of acetalde-
hyde could offer an explanation for the deleterious effect
of alcohol on various skin diseases, and that these prelim-
inary results warranted further in vivo study. However, to
our knowledge no further studies into this mechanism
were conducted. This research would be extremely impor-
tant, as the formation of acetaldehyde either by bacteria
strains on the human skin or by metabolism following
absorption is also a likely mechanism in topically applied
products. However, the amount of acetaldehyde forma-
tion after topical application of ethanol on intact, healthy
skin is currently unknown. The bacterial acetaldehyde
production may be restricted as both the transient and res-
ident microorganisms may be significantly reduced by the
ethanol application, which should lead to higher local
ethanol concentrations as in the case of systemic distribu-
tion after alcohol ingestion. In addition, the contact time
should be shorter in the case of topical ethanol applica-
tion because of the fast evaporation of the alcohol.
Ethanol as a penetration enhancer
Systematic in vitro and in vivo studies have elucidated the
mechanism of percutaneous alcohol absorption [1,49-
62]. Numerous data are available on permeability, parti-
tion coefficients and diffusion constants. It is now gener-
ally accepted that the "barrier" function of the skin resides
almost entirely in the stratum corneum [53,55,63,64].
Most water-soluble, low-molecular weight non-electro-
lytes – among them ethanol – applied to the skin surface
can diffuse much faster into the blood-stream if the epi-
dermis is diseased, damaged or removed [63].
Ethanol is also well known as a topical penetration
enhancer and may be used in transdermal delivery sys-
tems [65-81]. Bommannan et al. [82] found in vivo in
humans that ethanol enters the skin and removes measur-
able quantities of the lipid barrier material from the stra-
tum corneum. This lipid extraction may lower the skin
barrier function and render the membrane more permea-
ble, which is the most likely explanation for the effect of
ethanol as a skin penetration enhancer. Kai et al. [83] and
van der Merwe et al. [84] confirmed those results. Goates
et al. [85] additionally remarked that enhanced permea-
tion may be caused not only by extraction of lipids but
also of proteins from human skin in the presence of aque-
ous alcohol solutions. The mechanism of ethanol as a skin
permeation enhancer was described to be a so-called 'pull'
or 'drag' effect, which means that the permeation of the
enhancer subsequently facilitates that of the solute (in the
sense of a simple co-permeation) [79,80]. Side-effects of
the transdermal patches were cutaneous reactions, where
ethanol proved to be one of the causes of cutaneous intol-
erance or allergic contact dermatitis [86-89]. However, in
some of these cases combination effects between the dif-
ferent constituents of the preparation cannot be excluded,
so that it remains unclear if ethanol or other impurities
were the real cause for the allergic effects observed.
Animal studies demonstrated that both chronic and acute
ethanol consumption increase transdermal penetration,
resulting in higher exposure of several xenobiotics, e.g.
herbicides [90-92] or the tobacco carcinogen nitrosonor-
nicotine [93]. The transdermal absorption of xenobiotics
may be facilitated by ethanol induced changes in lipid
peroxidation and transepidermal water loss (TEWL)
[41,94]. In contrast, the influence of orally administered
ethanol on TEWL did not affect the penetration of a topi-
cally applied UV filter substance [95]. Changes in TEWL
were not only detected after ingestion of ethanol, but also
after topical application [77,96]. In contrast, other studies
found that there is no transepidermal water loss after top-
ical ethanol application [97,98].
Blood alcohol levels after ethanol absorption through skin
The previously mentioned studies about ethanol as a pen-
etration enhancer for pharmaceutical preparations show
that ethanol is absorbed into the normal, intact skin, and
may reach the blood stream to be systemically distributed
in the human body.
Anderson et al. [99] also confirmed these results using
microdialysis techniques, which showed that percutane-
ous absorption of alcohols can occur through intact skin.
Bowers et al. [100] reported a controlled study to assess
the likelihood of ethanol being absorbed through intact
skin and producing measurable blood-ethanol concentra-
tions in experiments involving four children (7–9 years of
age) and one adult. The legs of the subjects were wrapped
in cotton from above the knees to the feet, and the wrap-
pings were subsequently soaked with 200 ml of 95% (v/
v) ethanol. Although the ethanol-soaked cotton was kept
covering the skin with rubber sheeting and adhesive tapes
for 4–9 hours, no ethanol was measurable in the blood.
Schaefer and Redelmeier [6] estimated the percutaneously
absorbed dose of ethanol from a topical application.
Using Scheuplein and Blank's [54] permeability coeffi-
cient, a skin exposure area of 1000 cm2, and assuming aJournal of Occupational Medicine and Toxicology 2008, 3:26 http://www.occup-med.com/content/3/1/26
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maximum exposure period after topical application of sig-
nificantly less than 1 hr, they estimated that the percuta-
neous absorption of ethanol from a 70% solution would
be approximately 100 mg. Schaefer and Redelmeier
equated this amount of ethanol to that present in 1.5 ml
of wine containing 10% (v/v) ethanol, and therefore con-
cluded that "skin exposure to ethanol in cosmetics is not
a safety concern".
To our knowledge, the only study in the literature about
blood alcohol concentrations in humans after use of cos-
metics on the skin (alcohol based deodorant spray) was
conducted by Pendlington et al. [1]. Sixteen adults
sprayed an aerosol containing 44% ethanol over the body
for approximately 10 sec (mean amount used per treat-
ment: 9.72 g). Blood samples were taken after a 15 min
period. Subsequent samples were taken 5, 10, 30 and 60
min after that. Ten of the panellists produced at least one
blood sample with a detectable alcohol content (detec-
tion limit: 5 mg/l). The maximum value recorded was 13
mg/l. However, there remained some uncertainty in the
analytical method, as other alcohols may co-elute. Using
another gas chromatographic column (detection limit: 9
mg/l), none of the blood samples exhibited detectable
levels of ethanol. The application as a spray also includes
a potential pulmonary uptake. Despite the high concen-
tration of ethanol (44%) and the high exposure to large
surfaces, the maximum blood levels were only slightly ele-
vated above physiological blood levels (average 0.4 mg/l
[101]).
More information is available about the blood alcohol
concentrations arising from the use of alcohol-based dis-
infectants. Miller et al. [102] reported the blood alcohol
level after using an alcohol-based instant hand sanitizer
(62% (v/v) ethanol) under most extreme conditions
(applying 5 ml, 25 times over the course of 2 hours). The
blood alcohol level measured immediately following the
final application was below the detection limit (< 5 mg/
dl). In a subsequent study of 5 subjects using 5 ml of the
product with a repetition of 50 times over 4 hours, the
result was confirmed as all participants had blood ethanol
levels less than 5 mg/dl. No adverse reactions were noted
during the study [103]. The major constraint of the studies
of Miller et al. [102,103] is the relatively high detection
limit. Subsequent studies with more sensitive methods
showed that in fact detectable blood ethanol concentra-
tions may arise after using hand disinfectants. However,
the concentrations were judged by the authors as being
below acute toxic levels, i.e. ethanol was unable to cause
adverse effects within a short time of dosing or exposure
(acute and chronic toxicity are used according to IUPAC
definitions throughout the text [104]).
In the study of Kirschner et al. [5] with a detection limit of
0.5 mg/l, serum ethanol concentrations in the range of
1.0–1.5 mg/l were detected after application of 20 ml of
alcohol-containing disinfectant (74.1% ethanol) on a
200-cm2 gauze swab for 10 min. The exclusion of inhala-
tive uptake was given as rationale for the lower concentra-
tions in comparison to other studies. The dermal uptake
of ethanol was judged by the authors to be clinically insig-
nificant. In the study of Kramer et al. [4], 12 volunteers
applied three hand-rubs containing 95% (w/w), 85% (w/
w) or 55% (w/w) ethanol. 4 ml were applied 20 times for
30 s, with a 1 minute break between applications. The
highest median concentrations found were 20.95 mg/l,
11.45 mg/l and 6.9 mg/l, respectively. The proportion of
absorbed ethanol was 1365 mg (2.3%), 630 mg (1.1%),
and 358 mg (0.9%), respectively. In addition, blood
acetaldehyde was determined, the highest median of
which was 0.57 mg/l. It can be concurred with the authors
that acute toxic effects cannot be expected even after exces-
sive use of ethanol-based disinfectants. An impairment of
performance is usually assumed from blood ethanol con-
centrations of 200–300 mg/l and above [105]. Therefore,
the concentrations achieved by hand disinfectant use are
at least a factor of 10–20 below the values required for
acute toxicity. However, it is difficult to agree with
Schaefer and Redelmeier [6], Kirschner et al. [5] and
Kramer et al. [4] that the use of cosmetics or ethanol-
based hand rubs is "safe" per se. The chronic toxic effects
of ethanol and acetaldehyde have certainly to be
accounted for in the safety evaluation of topical ethanol
applications. This was done in neither of the above men-
tioned studies about the toxicity of skin disinfectants.
Ethanol absorption through lacerated skin: a health risk 
especially for children
The possibility of alcohol absorption across the injured
skin is generally accepted in the literature [63]. In 1950,
Paulus [106] conclusively showed in animal experiments
that alcohol is absorbed relatively rapidly through areas of
wounded skin. A human case relating to the absorption of
ethanol through abraised and lacerated skin was reported
by Jones et al. [107]. The damaged skin (33% of total
body surface) of a victim of a traffic accident was washed
in the operating theatre with surgical spirit (70% (v/v)
ethanol). A blood ethanol concentration of 0.046 g/100
ml was determined, which corresponded to an absorption
of approx. 30 ml of the ethanol solution. The authors con-
cluded that there is a risk of ethanol being absorbed into
the bloodstream if damaged skin is washed with surgical
spirits, which may have ramifications in civil litigation
(e.g. responsibility for accidents, insurance claims).
Alcohol is an agent that poses a risk of percutaneous tox-
icity in the newborn. Exposure of immature skin (espe-
cially under occlusion) may lead to significant localJournal of Occupational Medicine and Toxicology 2008, 3:26 http://www.occup-med.com/content/3/1/26
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reactions and systemic toxicity [108]. Percutaneous
absorption of ethanol through damaged skin resulting in
clinical manifestations of intoxication has been reported
in a 1-month-old infant [109] and in a 2-year-old child
[63]. Giménez et al. [110] reported ethanol poisoning in
28 children, aged one to 33 months, after application of
alcohol-soaked cloths to relieve abdominal pain (which
was a common practice in Argentina). Two of the children
with ethanol poisoning died. A fatal intoxication due to
percutaneous ethanol absorption in an infant was also
described by Niggemeyer et al. [111]. Skin necrosis and
elevated blood alcohol levels have also been observed in
preterm infants [112,113], whose immature, poorly kerat-
inized skin is an ineffective barrier to potentially toxic
compounds such as alcohol. In the case of the child intox-
ication mentioned above, the damage to the epidermis
accounted for an alcohol absorption rate approximately
1000 times faster than that across intact stratum corneum
[63].
Based on all scientific evidence alcohols including ethanol
are not recommended for use on abraised and lacerated
skin, and due to the expected burning sensation also not
for a cosmetic application.
Ethanol in mouthwashes and oral rinses
Ethanol is still a component of a significant number of
oral-care products [114]. When adults use such ethanol-
containing mouthwashes, oral rinses, and similar prod-
ucts as they are intended to be used, an acute-toxic effect
in the sense of typically intoxication occurring after alco-
holic beverage consumption caused by an increased
blood-alcohol level is not likely (note: the abusive inges-
tion of products intended for topical use will not be con-
sidered in this article; please refer to references [115-
119]).
The absence of acute-toxic effects in adults has previously
been interpreted to indicate that such mouth-rinsing cos-
metics are safe in every respect. However, the risk arising
from this product group does not result primarily from
systemic blood alcohol concentrations, but emanates
from the locally formed acetaldehyde (see section 'Carci-
nogenicity of ethanol' above). Further adverse effects of
the use of mouthwash were reviewed by Gagari et al.
[120]. For adults, these are predominantly local and sys-
temic allergic effects, which were postulated to be caused
by the combination of a high content of alcohol, an acidic
pH, and other ingredients that act individually or syner-
gistically. Furthermore, it was shown that the in vitro tox-
icity of ethanol-containing mouthwashes may exceed that
of pure-ethanol solutions [121]. Whereas, other in vitro
tests failed to detect mutagenic or carcinogenic hazards of
mouthwashes [122]. Other studies also reported the
opposite effect that ethanol containing mouthwashes may
be less toxic than formulations without ethanol in tissue
cultues of explants of neonatal rat peritoneum [123].
However, another recent study showed that the genotox-
icity of mouthwashes is caused by ethanol and not by any
other ingredient [124]. This is in line with mechanistic
evidence summarized by the IARC that ethanol causes sis-
ter chromatid exchange in both lower organisms and
mammalian cells, including human cells, and that the
data from studies in animals suggest that ethanol causes
DNA damage in target tissues [10].
Mechanistic evidence especially points to detrimental
effects of ethanol in the upper gastrointestinal tract (i.e.
the oral cavity, pharynx, larynx/hypopharynx). The
mucosa may be damaged by ethanol, which leads to the
stimulation of cell regeneration. Genetic changes may
then cause the development of dysplasia or leukoplakia
and, finally, cancer [125,126]. The possibility of damage
to the oral mucosa also exists with the use of mouth-
washes [127]. An overview of the effect of ethanol on the
oral mucosa is shown in Figure 1. Local damage to the
mucous membrane also facilitates the development of
tumours on such exposed locations by the increased
absorption of other carcinogenic substances. Besides
acetaldehyde, the microsomal metabolism of ethanol
leads to reactive oxygen species, which can also covalently
bind to the DNA [128]. Although the liver represents the
major site for cytochrome P450 (CYP) dependent metab-
olism, extrahepatic tissues including the buccal mucosa
may express CYP activity [129,130]. The contributions of
the different metabolic pathways to ethanol oxidation in
the oral mucosa after mouthwash consumption are cur-
rently unknown. Besides the metabolic conversion of eth-
anol in human cells, we have to consider oxidation of
ethanol into toxic acetaldehyde by microorganisms in the
oral cavity and the pharynx, which can be found in a phys-
iologically massive density [131-133]. It is remarkable
that many of the oral rinses found on the market have a
higher alcoholic strength than, for example, beer. There-
fore, the possibility of a very high acetaldehyde concentra-
tion in the saliva arises, even without ingestion of the
product (see below). For further information on the
molecular mechanisms of the carcinogenicity of alcohol,
the current review article of Seitz et al. [134] is recom-
mended.
Epidemiological studies on the link between mouthwash
use and oral cancer risk were recently reviewed by La Vec-
chia [135]. From the 10 case-control studies published
over the last three decades, three reported relative risks
above unity and seven no consistent association. How-
ever, in many cases the study designs were flawed as they
did not differentiate between alcohol-containing and
alcohol-free mouthwashes. One example is the multi-Journal of Occupational Medicine and Toxicology 2008, 3:26 http://www.occup-med.com/content/3/1/26
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center case-control study of Guha et al. [136] that indi-
cated daily mouthwash use as cause for cancers of the
head, neck and oesophagus, however, the association
remains dubious because the alcohol content and dura-
tion of use were not recorded.
Two of the studies that differentiated between mouth-
wash types found that the risk was correlated to the alco-
holic strength of the mouthwashes [137,138]. The risk
was confined to users of mouthwash high in alcohol con-
tent (>25% vol) [137]. An non-significantly elevated risk
was also observed among the small number of subjects
who neither smoked cigarettes nor drank alcohol in a
study conducted in Puerto-Rico [139]. Earlier studies also
reported limited evidence that the use of mouthwash may
be associated with an increase in the risk of oral cancer in
groups such as non-smoking, non-drinking women who
are ordinarily at a low risk [140,141].
From these limited results, it may be hypothesized that
the use of mouthwashes could have a threshold for
adverse effects (Figure 2). It is known that oral hygiene
may have an influence on risk for oral cancer [142], so the
use of mouthwash could reduce the acetaldehyde-produc-
ing oral microflora. However, there still exists the possibil-
ity for metabolic acetaldehyde production directly in the
mucosa by alcohol dehydrogenase.
According to Eriksson, the salivary acetaldehyde repre-
sents mostly microbial acetaldehyde formation in the oral
cavity, but also, to some extent, ethanol oxidation in
nearby tissues [143]. In vivo acetaldehyde production after
ethanol consumption is significantly reduced after a 3-day
use of an antiseptic mouthwash (chlorhexidine)
[144,145]. There are currently many research gaps regard-
ing mouthwash use. The analysis of the microbial flora
appears to be necessary for interpretation of acetaldehyde
levels in saliva after mouthwash use as well as the long
Simplified model of the mechanism of carcinogenesis in the oral mucosa after using ethanol-containing mouthrinses Figure 1
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term measurement of acetaldehyde levels, if alcoholic and
non-alcoholic antimicrobial mouthwashes are used.
Further research into the molecular mechanism of mouth-
wash mediated oral cancer is also needed. Furthermore,
the epidemiological evidence appears inadequate so far
[135,146-150], and larger case-control studies are neces-
sary that clearly differentiate between the different types
of mouthwash.
However, on this stage the currently available data pro-
vide, at the least, doubts about the general safety of alco-
hol-containing oral products. It appears to be prudent
precautionary public health policy to generally refrain
from using ethanol in such products. For example, the
Centers for Disease Control and Prevention (CDC) stated
that although there is no certain link between oral cancer
and mouthwash, its excessive use should be discouraged
[151].
It has been demonstrated a number of times that alcohol-
free oral rinses are as effective as their alcohol-containing
counterparts, and therefore the necessity for ethanol in
mouthwashes and oral rinses appears to be non-existent
[152-154]. Products without alcohol have also been
shown to have a lower incidence of other adverse effects
[155].
Ethanol in hand disinfectants
Ethanol-based hand disinfectants are widely used in occu-
pational settings not only in hospitals but also in all other
areas that demand hand-hygiene (e.g. food production).
The antimicrobial effects of alcohols (except methanol)
are based on protein denaturation [46]. Alcohols have
excellent, and the most rapid bactericidal and fungicidal
Hypothetical model for mouthwash related carcinogenic risk Figure 2
Hypothetical model for mouthwash related carcinogenic risk.Journal of Occupational Medicine and Toxicology 2008, 3:26 http://www.occup-med.com/content/3/1/26
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activity of all agents used in hand disinfection [156]. In
terms of antimicrobial efficacy, 1-propanol can be
regarded as the most effective alcohol, followed by 2-pro-
panol and ethanol [156]. Comparison of 2-propanol with
ethanol showed that the efficacy of 2-propanol 60% (v/v)
is almost equivalent to ethanol at 80% (v/v) [157]. Never-
theless, ethanol was described to be preferred because the
smell of isopropanol (2-propanol) was considered unac-
ceptably disagreeable [158]. However, the smell of a sub-
stance is of course toxicologically irrelevant and should
therefore not be a criterion to choose ethanol. While alco-
hol-based hand rubs generally have a broad and relatively
rapid activity against vegetative bacteria, they are often
limited in their ability to inactivate non-enveloped viruses
[159].
There is no unanimous view on the safety of ethanol-
based hand disinfectants in the scientific literature:
￿ On the one hand, alcohols were described as non-toxic
in their application as a hand disinfectant and they were
judged to lack any allergenic potential [156]. It was also
concluded that alcohol-based hand rubs have a less dele-
terious effect on the skin than other physical irritants,
which enhance skin reactivity [160]. The repetitive use of
different alcohol-based hand rubs was shown to not sig-
nificantly change transepidermal water loss, dermal water
content or the sebum content of the skin [98]. The poten-
tial of ethanol-containing hand rubs to cause skin irrita-
tion was tested using single and repetitive patch tests and
wash tests. No significant change in skin barrier or ery-
thema was induced, whereas skin hydration decreased sig-
nificantly. The wash tests demonstrated that alcohol
application caused significantly less skin irritation than
washing with a detergent. Even on previously irritated
skin, ethanol did not enhance irritation. Alcohol-based
hand rubs cause less skin irritation than hand washing,
and are therefore preferred for hand hygiene from the der-
matological point of view [97].
￿ On the other hand, the previously mentioned experi-
mental design used for evaluating the effects of alcohol-
based hand rubs on the skin (i.e. patch testing with single
alcohols) was criticized, because exposure to a wide vari-
ety of chemical irritants such as surfactants and detergents
is frequent. The effects of simultaneous application of dif-
ferent irritants had been shown to induce significantly
stronger reactions than those caused by application of
each irritant on its own [160]. Irritation with alcohols is
said to be common, and many healthcare workers com-
plain about non-acceptable skin irritation caused by alco-
hol-based hand rubs [160]. Allergic contact dermatitis or
contact urticaria syndrome induced by exposure to etha-
nol was previously described [86,87,161-175]. However,
especially with the use of ethanol in hand disinfectants,
the cause is not clear [159]. When reactions do occur, they
may be caused by hypersensitivity to the alcohol itself, to
aldehyde metabolites, or to some other additive of the
topically-applied products [86].
The most likely cause for reactions to ethanol applied to
the skin is the oxidative metabolism. Cytochrome P450,
alcohol dehydrogenase, and aldehyde dehydrogenase
(ALDH) activities have been demonstrated in skin [174].
However, large differences in genotype distribution were
observed between different ethnic groups, with the non-
functional ALDH2*2 allele being seen more commonly in
Asian populations [176]. ALDH deficiency has been sug-
gested to contribute to anaphylactic reactions to ethanol
[173,174,177].
Industry participation in studies about the safety of 
topically applied ethanol
Warnings can be found in the recent literature about sys-
tematic bias in scientific studies favouring products that
are made by the company funding the research [178-180].
It became evident that a number of studies dealing with
the safety of topically applied ethanol reviewed in this
article (especially those about mouthwashes and hand
disinfectants) were supported by industry, or at least one
of the researchers was a paid employee of a manufacturer
of the discussed product. The relevant studies are summa-
rized in Table 1 according to the outcome and industry
participation. It can be generally seen that the studies with
industry participation judged ethanol to be safe per se,
whereas independent studies were more cautious.
Patel [181] had previously questioned whether studies on
hand disinfectants were flawed due to a conflict of inter-
est, as one of the researchers was a paid employee of an
alcohol hand rub manufacturer included in the trial, and
the work was supported by grants from the manufacturer.
In the mouthwash studies, potential conflicts of interest
were detected by Mascarenhas [149] in the re-analysis of
Cole et al. [146] of the data from the National Cancer
Institute provided in the study of Winn et al. [137]. The
study of Cole et al. was financially supported by Warner-
Lambert Company (the former maker of Listerine). It is
interesting that from the same dataset, Winn et al. [137]
concluded that there is a significantly increased risk of oral
cancer associated with the regular use of mouthwash, but
Cole et al. [146] concluded that this association is
unlikely. The meta-analysis of Elmore et al. [147] financed
by Procter & Gamble Co. equally detected no support for
a link between mouthwash use and oral cancer. The recent
review of La Vecchia [135] on mouthwash was conducted
with partial unconditioned support from Johnson and
Johnson Consumer (the current maker of Listerine).Journal of Occupational Medicine and Toxicology 2008, 3:26 http://www.occup-med.com/content/3/1/26
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As it was evident in other areas of research [180], industry
supported reviews on ethanol should be read with cau-
tion, as they had more favourable conclusions than the
corresponding independent studies. To analyze the
research design of the industry-supported studies in ques-
tion in more detail would have gone beyond the scope of
the current article, so it remains uncertain if "industry
bias" or other factors such as superior design can explain
the differences in outcome of the studies. The possibility
for bias, however, suggests the requirement of further
independent research on alcohol-based hand disinfect-
ants as well as mouthwashes.
Legal aspects about ethanol and acetaldehyde in 
consumer products
Despite the above mentioned IARC evaluations, ethanol
itself is not yet classified as carcinogenic in the context of
European laws relating to dangerous substances [182].
Ethanol was also so far not evaluated by the Scientific
Committee on Consumer Products. For this reason, the
first metabolite of ethanol has to be used as a proxy
because such information is available only for acetalde-
hyde.
According to the EU regulations on dangerous substances,
acetaldehyde is categorized as a mutagenic and carcino-
genic substance in category 3 (CMR 3) [182]. This is in
accordance with the IARC that found sufficient evidence
in animals to demonstrate carcinogenicity of acetalde-
hyde, and therefore evaluated the substance as possibly
carcinogenic to humans also (group 2B) [183]. For those
reasons, the EU's scientific committee on cosmetic prod-
ucts and non-food products intended for consumers
(SCCNFP) has critically evaluated this substance [184].
Acetaldehyde is a constituent of many fragrance and fla-
vour compounds and therefore is a minor component in
a large number of cosmetic products (in the range
between 0.1 and 2 mg/kg). The human exposure to acetal-
dehyde in cosmetic products was estimated by the SCC-
NFP to be 0.1 μg/kg bodyweight/day. Nasal carcinomas
were detected during rat inhalation studies with acetalde-
hyde, and the threshold dosage was found to be HT25 =
36.7 mg/kg bodyweight/day, with which a neglectable
lifetime cancer risk of 7E-7 may be calculated according to
the T25-method of Sanner et al. [185]. The SCCNFP
briefly acknowledges the carcinogenic effect of acetalde-
hyde as a metabolite of ethanol in the context of alcoholic
beverages, but does not at all consider alcohol-containing
products in its opinion on acetaldehyde. For this reason,
the author thinks that it is likely that the SCCNFP has con-
siderably underestimated the human exposure to acetal-
dehyde. The SCCNFP evaluation could also be criticized
because it uses toxicological data from inhalation studies
to assess dermal exposure.
The risk assessment of the SCCNFP was not implemented
into the EU cosmetics directive 76/768/EEC [186]. How-
ever, the classification as a 'CMR 3 substance' explicitly
demands the introduction of acetaldehyde into Annex III
of the directive, because otherwise the substance would be
prohibited according to Article 4b, as it had to be listed in
Annex II of the directive. The risk management bodies of
the EU are currently discussing a maximum authorized
concentration of 20 mg/kg in the finished cosmetic prod-
uct. Such a rule, however, would not be applicable to
mouthwashes or most other consumer products because
acetaldehyde is not contained in the products themselves,
but only formed from ethanol during use in the oral cavity
or on the skin. For this reason the maximum value in the
European cosmetics directive cannot be used as a founda-
tion for legal restrictions on alcohol-containing consumer
products. Such restrictions would rather result from the
safety evaluation of the products (see conclusions). Pre-
liminary studies of mouthwashes have, for example,
shown that acetaldehyde may be contained in concentra-
tions up to 80 μmol/l in the saliva after rinsing with alco-
hol-containing mouthwashes, which was significantly
above endogenous levels [187]. The salivary concentra-
Table 1: Summary of articles about safety assessment of hand disinfectants and mouthwashes
Outcome of the study Studies with no obvious industry sponsorship 
or participation
Studies with co-authors from industry or 
studies with declared industry financing
Positive outcome ("ethanol is safe", "no link 
between mouthwash use and oral cancer", 
"unlikely that mouthwashes increase risk of 
developing oropharyngeal cancer")
[150] [1,4,5,135,146-148]
Negative or cautious outcome ("relationship 
between mouthwash use and oropharyngeal 
cancer", "conflicting findings in the literature", 
"mouthwashes probably irritate the oral 
mucosa", "further research needed")
[127,137-139,149]Journal of Occupational Medicine and Toxicology 2008, 3:26 http://www.occup-med.com/content/3/1/26
Page 11 of 16
(page number not for citation purposes)
tion may therefore reach the range of 40 to 200 μmol/l,
which is already able to cause mutagenic or carcinogenic
effects according to literature data [144,188].
All in all, there appears to be a legal void about the regu-
lation of ethanol in consumer and medicinal products.
Necessary future steps include the acknowledgment of
ethanol's carcinogenic properties in the laws on danger-
ous substances, as well as the safety assessment in the
framework of the laws about consumer and cosmetic
products.
Conclusion
The major conclusions of our literature review on the
safety of topically applied ethanol are summarized in the
Appendix.
The facts that ethanol is widely used in topical applica-
tions and that its adverse effects were seldom reported
should not be dismissed. But a confounding factor in any
study is the widespread use of alcoholic beverages. How-
ever, the prevalent consumption of alcoholic beverages in
our society cannot be used as an excuse to completely
negate any adverse effect of ethanol in cosmetic or other
topical preparations, especially in occupational settings
with high exposure to the ethanol containing products. As
was pointed out in some of the studies reviewed in this
article, the possibility exists that on the point of impact,
very high concentrations of ethanol and acetaldehyde
may cause chronic toxic effects. The effects may be more
pronounced in ALDH-deficient humans, but this associa-
tion demands further research.
Due to the conflicting evidence in many cases, the precau-
tionary toxicological principle should be currently
favoured in the evaluation of ethanol for topical uses.
Until unambiguous evidence about the safety of ethanol
in topical preparations exists, the necessity of its use
should be critically evaluated. In certain product groups
(e.g. mouthwashes), ethanol can be easily substituted for
other compounds. In other product groups - especially
hand disinfectants in hospital hygiene -, the advantages
for the patients may outweigh the potential risks for the
users. However, in this case, the formulations should be
critically evaluated if ethanol cannot be at least partially
substituted with e.g. other alcohols with a more favoura-
ble toxicological profile.
Assessment of cosmetic safety was introduced into Euro-
pean cosmetics law by Council Directive 93/35/EEC
(amending for the sixth time Directive 76/768/EEC on the
approximation of the laws relating to cosmetic products)
[8]. This Directive is an important instrument in the pro-
tection of consumer health in terms of the use of cosmetic
products. A re-examination and actualization of the safety
assessment is necessary if scientific evidence concerning
the ingredient employed in cosmetics changes [189]. With
respect to the past years' scientific findings about the car-
cinogenic properties of ethanol, and the recent re-evalua-
tion of this agent by the International Agency for Research
on Cancer (IARC), it seems necessary to re-evaluate and
actualize the safety assessment of topical products that
contain this alcohol.
Finally, an advancement in testing strategies for genotox-
icity and mutagenicity appears to be necessary [190], with
a refocus on testing the final formulation rather than the
isolated constituents [191]. The effect of ethanol as pene-
tration enhancer for other constituents of the formula-
tions must especially be considered in such a safety
evaluation of cosmetics.
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Appendix
Summary points and conclusions on the safety of topically 
applied ethanol
1. Topically applied ethanol (e.g. in the form of cosmetics
or hand disinfectants) on un-lacerated human skin will
not cause acute or systemic toxic effects, which can only
occur if applied on damaged skin especially in children.
2. Adverse effects of topically applied ethanol may include
skin irritations or allergic contact dermatitis.
3. Ethanol and its metabolite, acetaldehyde, are poten-
tially carcinogenic for humans, however, only limited evi-
dence supports the carcinogenicity of mouthwashes, and
a complete lack of data about the carcinogenicity of all
other groups of products (e.g. cosmetics, hand disinfect-
ants) was detected.Journal of Occupational Medicine and Toxicology 2008, 3:26 http://www.occup-med.com/content/3/1/26
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4. Further concerns include the permeation-enhancing
capabilities of ethanol, which could lead to an increased
absorption of other components of topically applied for-
mulations (e.g. nitrosamines from cosmetics).
5. Safety assessments of ethanol in any form of applica-
tion must include the carcinogenic and genotoxic proper-
ties of ethanol and its metabolite acetaldehyde.
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